Ventricular assist devices in the management of terminal heart failure;Mechanické srdeční podpory v terapii terminálního srdečního selhání

Cor et Vasa

Volumn 50, Issue 5, 2008, Pages 207-214

  Netuka, Ivan ^a   Malý, Jiří ^a   Szárszoi, Ondrej ^a  

^a Institut klinické a Expertmentálni Medicíny   (Czech Republic)

Author keywords

Bridge to transplantation; Terminal heart failure; Ventricular assist device

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HEMOLYSIS; HUMAN; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; SENSITIZATION; TERMINAL DISEASE; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 44349194243     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2008.069     Document Type: Article

References (32)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
2. Akutsu T, Kolff W. Permanent substitutes for valves and heart. Trans Am Soc Artific Intern Organs 1958;4:230.
3. De Vries W. Clinical use of the total artificial heart. N Engl J Med 1984;310:273-8.
4. Vašků J, Černý J, Dostál M, et al. Comparative study of the implantation of a hybrid total artificial heart (TAH) TNS-BRNO-II and TNS-BRNO-VII. Life Support Syst 1985:3 (Suppl 1):211-4.
5. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-9.
6. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg 2007;133:1573-80.
7. Wieselthaler GM, Schima H, Hiesmayr M, et al. First clinical experience with the DeBakey VAD continuous - axial-flow pump for bridge to transplantation. Circulation 2000;101:356-9.
8. Thalmann M, Schima H, Wiesenthaler G, Wolner E. Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 2005;24:237-45.
9. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous - flow left ventricular assist devices. Circulation 2007; 116 (Suppl):I8-I15.
10. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
11. Westaby S, Frazier OH, Banning A, et al. Six years of continuous mechanical circulatory support. N Engl J Med 2006;355:325-7.
12. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 1997;95:1844-52.
13. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003;108:3059-63.
14. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96.
15. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-36.
16. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to - recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21.
17. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007;28:613-27.
18. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.
19. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351-8.
20. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122: 1186-95.
21. Rose EA, Gelijns AC, Maskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
22. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
23. Haddad H, Elabbassi W, Moustafa S, et al. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J 2005;51:456-60.
24. Salzberg SP, Lachat ML, Von Harbou K, Zund G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 2005;27:222-5.
25. Martin J, Siegenthaler MP, Friesewinkel O, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 2004;25:971-7.
26. Zimpfer D, Zrunek P, Roethy W, et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007;133:689-95.
27. Zimpfer D, Zrunek P, Sandner S, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 2007;31:698-702.
28. Drakos SG, Stringham JC, Long JW, et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg 2007;133:1612-9.
29. Drakos SG, Kfoury AG, Long JW, et al. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg 2006;82:889-93.
30. Kettner J. Mechanické podpory krevního oběhu. Cor Vasa 2003;45:437-43.
31. Kettner J, Pirk J, Netuka I, et al. Mechanical cardiac support - the first use in Czech Republic. Čas Lék čes 2005; 144:38-42.
32. Kettner J, Pirk J, Netuka I, et al. První použití mechanické srdeční podpory v České republice. Interv Akut Kardiol 2004;2:4-6